The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.
Identifieur interne : 000631 ( PubMed/Checkpoint ); précédent : 000630; suivant : 000632The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.
Auteurs : Jacques Pépin [Canada] ; François Sobela ; Nzambi Khonde ; Thomas Agyarko-Poku ; Soumaila Diakité ; Sylvie Deslandes ; Annie-Claude Labbé ; Mohamed Sylla ; Comfort Asamoah-Adu ; Eric FrostSource :
- Bulletin of the World Health Organization [ 0042-9686 ] ; 2006.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Afrique de l'Ouest, Animaux, Anti-infectieux (administration et posologie), Anti-infectieux (usage thérapeutique), Antifongiques (administration et posologie), Antifongiques (usage thérapeutique), Antitrichomonas (administration et posologie), Antitrichomonas (usage thérapeutique), Association de médicaments, Candida (), Clotrimazole (administration et posologie), Clotrimazole (usage thérapeutique), Enfant, Femelle, Fluconazole (administration et posologie), Fluconazole (usage thérapeutique), Humains, Mycoplasma genitalium (), Métronidazole (administration et posologie), Métronidazole (usage thérapeutique), Neisseria gonorrhoeae (), Perte vaginale (microbiologie), Perte vaginale (parasitologie), Perte vaginale (traitement médicamenteux), Prostitution, Résultat thérapeutique, Syndrome, Tinidazole (administration et posologie), Tinidazole (usage thérapeutique), Trichomonas vaginalis ().
- MESH :
- administration et posologie : Anti-infectieux, Antifongiques, Antitrichomonas, Clotrimazole, Fluconazole, Métronidazole, Tinidazole.
- microbiologie : Perte vaginale.
- parasitologie : Perte vaginale.
- traitement médicamenteux : Perte vaginale.
- usage thérapeutique : Anti-infectieux, Antifongiques, Antitrichomonas, Clotrimazole, Fluconazole, Métronidazole, Tinidazole.
- Adolescent, Adulte, Afrique de l'Ouest, Animaux, Association de médicaments, Candida, Enfant, Femelle, Humains, Mycoplasma genitalium, Neisseria gonorrhoeae, Prostitution, Résultat thérapeutique, Syndrome, Trichomonas vaginalis.
English descriptors
- KwdEn :
- Adolescent, Adult, Africa, Western, Animals, Anti-Infective Agents (administration & dosage), Anti-Infective Agents (therapeutic use), Antifungal Agents (administration & dosage), Antifungal Agents (therapeutic use), Antitrichomonal Agents (administration & dosage), Antitrichomonal Agents (therapeutic use), Candida (drug effects), Child, Clotrimazole (administration & dosage), Clotrimazole (therapeutic use), Drug Therapy, Combination, Female, Fluconazole (administration & dosage), Fluconazole (therapeutic use), Humans, Metronidazole (administration & dosage), Metronidazole (therapeutic use), Mycoplasma genitalium (drug effects), Neisseria gonorrhoeae (drug effects), Sex Work, Syndrome, Tinidazole (administration & dosage), Tinidazole (therapeutic use), Treatment Outcome, Trichomonas vaginalis (drug effects), Vaginal Discharge (drug therapy), Vaginal Discharge (microbiology), Vaginal Discharge (parasitology).
- MESH :
- chemical , administration & dosage : Anti-Infective Agents, Antifungal Agents, Antitrichomonal Agents, Clotrimazole, Fluconazole, Metronidazole, Tinidazole.
- chemical , therapeutic use : Anti-Infective Agents, Antifungal Agents, Antitrichomonal Agents, Clotrimazole, Fluconazole, Metronidazole, Tinidazole.
- drug effects : Candida, Mycoplasma genitalium, Neisseria gonorrhoeae, Trichomonas vaginalis.
- drug therapy : Vaginal Discharge.
- microbiology : Vaginal Discharge.
- parasitology : Vaginal Discharge.
- Adolescent, Adult, Africa, Western, Animals, Child, Drug Therapy, Combination, Female, Humans, Sex Work, Syndrome, Treatment Outcome.
Abstract
To evaluate whether single-dose treatments are as effective as standard therapy in the syndromic management of vaginal discharge.
PubMed: 17128343
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:17128343Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.</title><author><name sortKey="Pepin, Jacques" sort="Pepin, Jacques" uniqKey="Pepin J" first="Jacques" last="Pépin">Jacques Pépin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Infectious Diseases, Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec, Canada. jacques.pepin@usherbrooke.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Microbiology and Infectious Diseases, Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author><author><name sortKey="Sobela, Francois" sort="Sobela, Francois" uniqKey="Sobela F" first="François" last="Sobela">François Sobela</name></author><author><name sortKey="Khonde, Nzambi" sort="Khonde, Nzambi" uniqKey="Khonde N" first="Nzambi" last="Khonde">Nzambi Khonde</name></author><author><name sortKey="Agyarko Poku, Thomas" sort="Agyarko Poku, Thomas" uniqKey="Agyarko Poku T" first="Thomas" last="Agyarko-Poku">Thomas Agyarko-Poku</name></author><author><name sortKey="Diakite, Soumaila" sort="Diakite, Soumaila" uniqKey="Diakite S" first="Soumaila" last="Diakité">Soumaila Diakité</name></author><author><name sortKey="Deslandes, Sylvie" sort="Deslandes, Sylvie" uniqKey="Deslandes S" first="Sylvie" last="Deslandes">Sylvie Deslandes</name></author><author><name sortKey="Labbe, Annie Claude" sort="Labbe, Annie Claude" uniqKey="Labbe A" first="Annie-Claude" last="Labbé">Annie-Claude Labbé</name></author><author><name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name></author><author><name sortKey="Asamoah Adu, Comfort" sort="Asamoah Adu, Comfort" uniqKey="Asamoah Adu C" first="Comfort" last="Asamoah-Adu">Comfort Asamoah-Adu</name></author><author><name sortKey="Frost, Eric" sort="Frost, Eric" uniqKey="Frost E" first="Eric" last="Frost">Eric Frost</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17128343</idno><idno type="pmid">17128343</idno><idno type="wicri:Area/PubMed/Corpus">000850</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000850</idno><idno type="wicri:Area/PubMed/Curation">000850</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000850</idno><idno type="wicri:Area/PubMed/Checkpoint">000850</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000850</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.</title><author><name sortKey="Pepin, Jacques" sort="Pepin, Jacques" uniqKey="Pepin J" first="Jacques" last="Pépin">Jacques Pépin</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Infectious Diseases, Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec, Canada. jacques.pepin@usherbrooke.ca</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Microbiology and Infectious Diseases, Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author><author><name sortKey="Sobela, Francois" sort="Sobela, Francois" uniqKey="Sobela F" first="François" last="Sobela">François Sobela</name></author><author><name sortKey="Khonde, Nzambi" sort="Khonde, Nzambi" uniqKey="Khonde N" first="Nzambi" last="Khonde">Nzambi Khonde</name></author><author><name sortKey="Agyarko Poku, Thomas" sort="Agyarko Poku, Thomas" uniqKey="Agyarko Poku T" first="Thomas" last="Agyarko-Poku">Thomas Agyarko-Poku</name></author><author><name sortKey="Diakite, Soumaila" sort="Diakite, Soumaila" uniqKey="Diakite S" first="Soumaila" last="Diakité">Soumaila Diakité</name></author><author><name sortKey="Deslandes, Sylvie" sort="Deslandes, Sylvie" uniqKey="Deslandes S" first="Sylvie" last="Deslandes">Sylvie Deslandes</name></author><author><name sortKey="Labbe, Annie Claude" sort="Labbe, Annie Claude" uniqKey="Labbe A" first="Annie-Claude" last="Labbé">Annie-Claude Labbé</name></author><author><name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name></author><author><name sortKey="Asamoah Adu, Comfort" sort="Asamoah Adu, Comfort" uniqKey="Asamoah Adu C" first="Comfort" last="Asamoah-Adu">Comfort Asamoah-Adu</name></author><author><name sortKey="Frost, Eric" sort="Frost, Eric" uniqKey="Frost E" first="Eric" last="Frost">Eric Frost</name></author></analytic><series><title level="j">Bulletin of the World Health Organization</title><idno type="ISSN">0042-9686</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Africa, Western</term><term>Animals</term><term>Anti-Infective Agents (administration & dosage)</term><term>Anti-Infective Agents (therapeutic use)</term><term>Antifungal Agents (administration & dosage)</term><term>Antifungal Agents (therapeutic use)</term><term>Antitrichomonal Agents (administration & dosage)</term><term>Antitrichomonal Agents (therapeutic use)</term><term>Candida (drug effects)</term><term>Child</term><term>Clotrimazole (administration & dosage)</term><term>Clotrimazole (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Female</term><term>Fluconazole (administration & dosage)</term><term>Fluconazole (therapeutic use)</term><term>Humans</term><term>Metronidazole (administration & dosage)</term><term>Metronidazole (therapeutic use)</term><term>Mycoplasma genitalium (drug effects)</term><term>Neisseria gonorrhoeae (drug effects)</term><term>Sex Work</term><term>Syndrome</term><term>Tinidazole (administration & dosage)</term><term>Tinidazole (therapeutic use)</term><term>Treatment Outcome</term><term>Trichomonas vaginalis (drug effects)</term><term>Vaginal Discharge (drug therapy)</term><term>Vaginal Discharge (microbiology)</term><term>Vaginal Discharge (parasitology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Afrique de l'Ouest</term><term>Animaux</term><term>Anti-infectieux (administration et posologie)</term><term>Anti-infectieux (usage thérapeutique)</term><term>Antifongiques (administration et posologie)</term><term>Antifongiques (usage thérapeutique)</term><term>Antitrichomonas (administration et posologie)</term><term>Antitrichomonas (usage thérapeutique)</term><term>Association de médicaments</term><term>Candida ()</term><term>Clotrimazole (administration et posologie)</term><term>Clotrimazole (usage thérapeutique)</term><term>Enfant</term><term>Femelle</term><term>Fluconazole (administration et posologie)</term><term>Fluconazole (usage thérapeutique)</term><term>Humains</term><term>Mycoplasma genitalium ()</term><term>Métronidazole (administration et posologie)</term><term>Métronidazole (usage thérapeutique)</term><term>Neisseria gonorrhoeae ()</term><term>Perte vaginale (microbiologie)</term><term>Perte vaginale (parasitologie)</term><term>Perte vaginale (traitement médicamenteux)</term><term>Prostitution</term><term>Résultat thérapeutique</term><term>Syndrome</term><term>Tinidazole (administration et posologie)</term><term>Tinidazole (usage thérapeutique)</term><term>Trichomonas vaginalis ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Infective Agents</term><term>Antifungal Agents</term><term>Antitrichomonal Agents</term><term>Clotrimazole</term><term>Fluconazole</term><term>Metronidazole</term><term>Tinidazole</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Infective Agents</term><term>Antifungal Agents</term><term>Antitrichomonal Agents</term><term>Clotrimazole</term><term>Fluconazole</term><term>Metronidazole</term><term>Tinidazole</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-infectieux</term><term>Antifongiques</term><term>Antitrichomonas</term><term>Clotrimazole</term><term>Fluconazole</term><term>Métronidazole</term><term>Tinidazole</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Candida</term><term>Mycoplasma genitalium</term><term>Neisseria gonorrhoeae</term><term>Trichomonas vaginalis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Vaginal Discharge</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Perte vaginale</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Vaginal Discharge</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Perte vaginale</term></keywords><keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Vaginal Discharge</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Perte vaginale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-infectieux</term><term>Antifongiques</term><term>Antitrichomonas</term><term>Clotrimazole</term><term>Fluconazole</term><term>Métronidazole</term><term>Tinidazole</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Africa, Western</term><term>Animals</term><term>Child</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Sex Work</term><term>Syndrome</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Afrique de l'Ouest</term><term>Animaux</term><term>Association de médicaments</term><term>Candida</term><term>Enfant</term><term>Femelle</term><term>Humains</term><term>Mycoplasma genitalium</term><term>Neisseria gonorrhoeae</term><term>Prostitution</term><term>Résultat thérapeutique</term><term>Syndrome</term><term>Trichomonas vaginalis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To evaluate whether single-dose treatments are as effective as standard therapy in the syndromic management of vaginal discharge.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17128343</PMID><DateCreated><Year>2006</Year><Month>11</Month><Day>27</Day></DateCreated><DateCompleted><Year>2006</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-9686</ISSN><JournalIssue CitedMedium="Print"><Volume>84</Volume><Issue>9</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Bulletin of the World Health Organization</Title><ISOAbbreviation>Bull. World Health Organ.</ISOAbbreviation></Journal><ArticleTitle>The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.</ArticleTitle><Pagination><MedlinePgn>729-38</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate whether single-dose treatments are as effective as standard therapy in the syndromic management of vaginal discharge.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A randomized controlled effectiveness trial compared single-dose tinidazole plus fluconazole (TF) with treatment for 7 days with metronidazole plus 3 days of treatment with vaginal clotrimazole (MC) among 1570 women presenting with vaginal discharge at primary health care institutions in Ghana, Guinea, Mali and Togo. Participants were randomly allocated to one of the two treatments by research nurses or physicians using precoded envelopes. Effectiveness was assessed by symptomatic response on day 14. CLINICAL IDENTIFIER ClinicalTrials.gov NCT00313131.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The two treatment regimens had similar effectiveness: complete resolution was seen in 66% (TF) and 64% (MC) and partial resolution in 33% (TF) and 34% (MC) of participants (P = 0.26). Effectiveness was similar among subgroups with vulvovaginal candidiasis, Trichomonas vaginalis vaginitis or bacterial vaginosis. The two treatment regimens had a similar effectiveness among human immunodeficiency virus (HIV)-infected (TF: n = 76, 71% complete resolution, 28% partial; MC: n = 83, 72% complete resolution, 25% partial, P = 0.76) and HIV-uninfected women (TF: n = 517, 68% complete, 32% partial; MC: n = 466, 65% complete, 33% partial, P = 0.20). Cervical infections with Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium were uncommon among women not involved in sex work, were associated with bacterial vaginosis or T. vaginalis vaginitis, and did not alter response to treatment with agents active against vaginal infections. Four-fifths of women not relieved by a single dose of TF had a favourable response when MC was administered as second-line treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Single-dose TF is as effective as multiple-dose MC in the syndromic management of vaginal discharge, even among women with HIV-infection. Given its low price and easier adherence, TF should be considered as a first-line treatment for vaginal discharge syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pépin</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Diseases, Centre Hospitalier Universitaire de Sherbrooke, University of Sherbrooke, 3001 12th Avenue North, Sherbrooke, Quebec, Canada. jacques.pepin@usherbrooke.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobela</LastName><ForeName>François</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Khonde</LastName><ForeName>Nzambi</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Agyarko-Poku</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Diakité</LastName><ForeName>Soumaila</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Deslandes</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Labbé</LastName><ForeName>Annie-Claude</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Sylla</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Asamoah-Adu</LastName><ForeName>Comfort</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Frost</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00313131</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Bull World Health Organ</MedlineTA><NlmUniqueID>7507052</NlmUniqueID><ISSNLinking>0042-9686</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000994">Antitrichomonal Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>033KF7V46H</RegistryNumber><NameOfSubstance UI="D014011">Tinidazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>140QMO216E</RegistryNumber><NameOfSubstance UI="D008795">Metronidazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>8VZV102JFY</RegistryNumber><NameOfSubstance UI="D015725">Fluconazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>G07GZ97H65</RegistryNumber><NameOfSubstance UI="D003022">Clotrimazole</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000354" MajorTopicYN="N">Africa, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000994" MajorTopicYN="N">Antitrichomonal Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002175" MajorTopicYN="N">Candida</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003022" MajorTopicYN="N">Clotrimazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015725" MajorTopicYN="N">Fluconazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008795" MajorTopicYN="N">Metronidazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045704" MajorTopicYN="N">Mycoplasma genitalium</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011477" MajorTopicYN="N">Sex Work</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014011" MajorTopicYN="N">Tinidazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014246" MajorTopicYN="N">Trichomonas vaginalis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019522" MajorTopicYN="N">Vaginal Discharge</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2627470</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>01</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>12</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17128343</ArticleId><ArticleId IdType="pii">S0042-96862006000900016</ArticleId><ArticleId IdType="pmc">PMC2627470</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Agyarko Poku, Thomas" sort="Agyarko Poku, Thomas" uniqKey="Agyarko Poku T" first="Thomas" last="Agyarko-Poku">Thomas Agyarko-Poku</name><name sortKey="Asamoah Adu, Comfort" sort="Asamoah Adu, Comfort" uniqKey="Asamoah Adu C" first="Comfort" last="Asamoah-Adu">Comfort Asamoah-Adu</name><name sortKey="Deslandes, Sylvie" sort="Deslandes, Sylvie" uniqKey="Deslandes S" first="Sylvie" last="Deslandes">Sylvie Deslandes</name><name sortKey="Diakite, Soumaila" sort="Diakite, Soumaila" uniqKey="Diakite S" first="Soumaila" last="Diakité">Soumaila Diakité</name><name sortKey="Frost, Eric" sort="Frost, Eric" uniqKey="Frost E" first="Eric" last="Frost">Eric Frost</name><name sortKey="Khonde, Nzambi" sort="Khonde, Nzambi" uniqKey="Khonde N" first="Nzambi" last="Khonde">Nzambi Khonde</name><name sortKey="Labbe, Annie Claude" sort="Labbe, Annie Claude" uniqKey="Labbe A" first="Annie-Claude" last="Labbé">Annie-Claude Labbé</name><name sortKey="Sobela, Francois" sort="Sobela, Francois" uniqKey="Sobela F" first="François" last="Sobela">François Sobela</name><name sortKey="Sylla, Mohamed" sort="Sylla, Mohamed" uniqKey="Sylla M" first="Mohamed" last="Sylla">Mohamed Sylla</name></noCountry><country name="Canada"><noRegion><name sortKey="Pepin, Jacques" sort="Pepin, Jacques" uniqKey="Pepin J" first="Jacques" last="Pépin">Jacques Pépin</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000631 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000631 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:17128343
|texte= The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:17128343" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |